📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-09 17:58
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
15 announcements match the current filters (relevance ≥ 5).
DSFCL Seeks Approval for Rs 70.12 Cr Public & Member Deposits and Board Appointments
DCM Shriram Fine Chemicals Limited (DSFCL) has issued a Postal Ballot Notice seeking shareholder approval for key board appointments and the acceptance of public deposits. Following its demerger scheme, the company plans to raise unsecured fixed deposits with statutory limits capped at Rs 50.09 crore for public deposits (25% limit) and Rs 20.03 crore for member deposits (10% limit). Additionally, shareholders will vote on the 5-year appointment of Rudra Shriram as Managing Director and three Non-Executive Independent Directors. Remote e-voting runs from September 11, 2026, to October 10, 2026, with results declared on October 10, 2026.
Confidence: HIGH
What changedDSFCL is formally seeking shareholder sanction via postal ballot to accept up to Rs 70.12 crore in fixed deposits and confirm its board leadership post-demerger.
Why it mattersEnables an alternative working capital funding channel while establishing corporate governance with the appointment of an MD and three independent directors.
Public Deposit Limit: Rs. 50.09 CrMember Deposit Limit: Rs. 20.03 CrE-voting End Date: October 10, 2026Cut-off Date: September 4, 2026
📅 Short termShareholders are expected to vote on the resolutions through October 10, 2026; no immediate impact on market trading is anticipated.
📈 Long termFixed deposits will provide diversified, low-cost working capital to support the chemical business operations following the scheme of arrangement.
⚠ Risk flags
- Credit rating dependency for the fixed deposit program limits
- Unsecured borrowing increases debt service obligations
Key Highlights
Proposed limit of Rs 50.09 Cr for acceptance of unsecured deposits from the public (25% statutory cap)
Proposed limit of Rs 20.03 Cr for deposits from members (10% statutory cap)
Appointment of Mr. Rudra Shriram as Director and Managing Director for a 5-year term
Remote e-voting window opens September 11, 2026, and concludes October 10, 2026
👀 What to Watch
Track the e-voting results on October 10, 2026, and monitor the credit rating assigned to the planned deposit program, which will dictate borrowing costs.
Rs 90.78 Cr Q1 Revenue: DCM Shriram Fine Chemicals Appoints Rudra Shriram as MD
DCM Shriram Fine Chemicals has appointed Mr. Rudra Shriram as Managing Director for a five-year term starting August 15, 2026, following the resignation of Mr. Akshay Dhar. Mr. Dhar will transition to leading the company's expansion and new project initiatives. For the quarter ended June 30, 2026, the company reported a standalone revenue of Rs 90.78 crore, representing a 7.9% decline from Rs 98.62 crore in the corresponding quarter of the previous year. Additionally, Mr. Rakesh Malhotra was appointed as an Independent Director for a five-year period.
Confidence: HIGH
What changedThe company has transitioned its leadership to a member of the promoter family (Shriram) and reported its first-quarter financial results for FY27.
Why it mattersThe leadership change occurs during a period of declining revenue (down 7.9% YoY), making the execution of expansion projects critical for maintaining the company's growth trajectory in the specialty chemicals sector.
Q1 FY27 Standalone Revenue: Rs 90.78 crQ1 FY26 Standalone Revenue: Rs 98.62 crFY26 Annual Revenue: Rs 385.55 crMD Appointment Tenure: 5 yearsSubsidiary Net Profit: Rs 17.73 lakhs
📅 Short termThe stock may see neutral to slightly cautious movement as the market digests the revenue dip and the management transition.
📈 Long termThe long-term outlook depends on the successful execution of the expansion initiatives led by the former MD and the strategic direction under the new MD.
⚠ Risk flags
- Revenue contraction of 7.9% YoY
- Transition risk associated with leadership change
Key Highlights
Mr. Rudra Shriram appointed as Managing Director for a 5-year term effective August 15, 2026.
Standalone revenue for Q1 FY27 reported at Rs 90.78 crore, a 7.9% decrease from Rs 98.62 crore YoY.
Outgoing MD Mr. Akshay Dhar to focus on leading new projects and expansion initiatives.
Consolidated subsidiary Daurala Foods & Beverages reported a net profit of Rs 17.73 lakhs for the quarter.
Mr. Rakesh Malhotra appointed as an Independent Director for a 5-year tenure.
👀 What to Watch
Investors should monitor the progress of the 'new projects and expansion initiatives' mentioned as the reason for the leadership transition, as these will be key to reversing the current revenue contraction.
DCM Shriram Fine Chemicals: MD & CEO Resigns; Q1 Revenue Declines 7.9% YoY to Rs 90.78 Cr
DCM Shriram Fine Chemicals announced a leadership transition as Mr. Akshay Dhar resigned as MD & CEO effective August 14, 2026, to focus on the company's expansion initiatives. He is succeeded by Mr. Rudra Shriram, appointed as Managing Director for a 5-year term. Financially, the company reported a standalone revenue of Rs 90.78 crore for Q1 FY27, a 7.9% decline compared to Rs 98.62 crore in the same quarter last year. The board also appointed Mr. Rakesh Malhotra as an Independent Director for 5 years.
Confidence: HIGH
What changedA change in top leadership with a new Managing Director taking over, alongside the release of Q1 FY27 financial results showing a revenue contraction.
Why it mattersLeadership transitions in promoter-led companies often signal a shift in strategic focus; the revenue decline highlights a challenging period for the specialty chemicals business.
Q1 FY27 Standalone Revenue: Rs 90.78 crYoY Revenue Growth: -7.9%QoQ Revenue Growth: -2.5%MD Appointment Term: 5 yearsSubsidiary Revenue (Q1): Rs 24.17 lakhs
📅 Short termThe stock may see neutral to slightly negative sentiment due to the year-on-year revenue decline and the departure of the current CEO.
📈 Long termThe long-term outlook depends on the execution of the expansion projects that the outgoing CEO is moving to lead and the new MD's ability to stabilize revenue.
⚠ Risk flags
- Revenue contraction on both YoY and QoQ basis
- Management transition risk
Key Highlights
Standalone revenue for Q1 FY27 reported at Rs 90.78 crore, down from Rs 98.62 crore YoY.
Mr. Rudra Shriram appointed as Managing Director for a 5-year term starting August 15, 2026.
Outgoing CEO Akshay Dhar to transition into leading new projects and expansion initiatives.
Quarterly revenue showed a sequential decline of 2.5% from Rs 93.08 crore in March 2026.
Subsidiary Daurala Foods & Beverages reported a small net profit of Rs 17.73 lakhs for the quarter.
👀 What to Watch
Investors should monitor the progress of the 'new projects and expansion initiatives' mentioned as the reason for the leadership shift, as these will be critical for reversing the current revenue decline.
Rs 90.78 Cr Q1 Revenue: DSFCL Announces Major Leadership Transition for Expansion Focus
DCM Shriram Fine Chemicals reported Q1 FY27 consolidated revenue of Rs 90.78 crore, representing a 7.9% year-on-year decline from Rs 98.62 crore. The company is undergoing a significant leadership shift, with Mr. Rudra Shriram appointed as Managing Director for a 5-year term effective August 15, 2026. Outgoing MD & CEO Mr. Akshay Dhar will transition to a new role specifically focused on leading the company's expansion initiatives and new projects. Additionally, Mr. Rakesh Malhotra joins the board as an Independent Director for a 5-year tenure.
Confidence: HIGH
What changedThe company reported a decline in quarterly revenue and restructured its top management, moving the current CEO to a project-focused role and appointing a new MD.
Why it mattersThe leadership transition suggests a strategic pivot toward expansion and new projects, which is critical for a specialty chemicals player, though the current revenue contraction warrants caution.
Q1 FY27 Revenue: Rs 90.78 crQ1 FY26 Revenue: Rs 98.62 crRevenue Growth (YoY): -7.95%Subsidiary PAT: Rs 17.73 lakhsMD Appointment Term: 5 years
📅 Short termThe stock may see neutral to slightly cautious movement due to the revenue decline, while the market digests the management changes.
📈 Long termThe structural significance depends on the execution of the expansion initiatives mentioned in the leadership transition; success here could re-rate the business.
⚠ Risk flags
- Revenue contraction on a YoY basis
- Management transition risk during a period of declining sales
Key Highlights
Consolidated revenue for Q1 FY27 stood at Rs 90.78 crore, down from Rs 98.62 crore in Q1 FY26
Mr. Rudra Shriram appointed as Managing Director for a 5-year term starting August 15, 2026
Outgoing MD Mr. Akshay Dhar to lead new projects and expansion initiatives specifically
Subsidiary Daurala Foods & Beverages contributed Rs 24.17 lakhs in revenue and Rs 17.73 lakhs in PAT
Mr. Rakesh Malhotra appointed as Independent Director for a period of 5 years
👀 What to Watch
Investors should monitor the specific details and capital outlay of the 'new projects' to be led by the outgoing CEO, as this will determine the company's future growth trajectory.
DSFCL Q1 Revenue Declines 7.9% YoY to ₹90.78 Cr; MD & CEO Akshay Dhar Resigns
DSFCL reported a consolidated revenue of ₹90.78 crore for the quarter ended June 30, 2026, marking a 7.9% decline from ₹98.62 crore in the same period last year. Sequentially, revenue also dipped 2.5% from the March 2026 quarter. In a significant leadership shift, Mr. Akshay Dhar has resigned as MD & CEO to lead the company's expansion initiatives, with Mr. Rudra Shriram appointed as the new MD for a 5-year term. The company's subsidiary, Daurala Foods & Beverages, contributed a marginal profit of ₹17.73 lakhs.
Confidence: HIGH
What changedRevenue has contracted both annually and sequentially, and the company has undergone a top-level leadership change with a new Managing Director.
Why it mattersThe revenue decline suggests potential volume or pricing pressure in the specialty chemicals segment, while the leadership transition during a period of contraction adds execution risk to upcoming expansion plans.
Revenue (Q1 FY27): ₹90.78 crRevenue Growth (YoY): -7.9%Revenue Growth (QoQ): -2.5%Subsidiary PAT: ₹17.73 lakhsMD Appointment Term: 5 years
📅 Short termThe stock may face negative sentiment in the short term due to the combined impact of declining revenues and the departure of the sitting CEO.
📈 Long termLong-term value depends on the success of the 'expansion initiatives' the outgoing CEO is moving to lead; however, current organic growth is currently negative.
⚠ Risk flags
- Revenue contraction
- Key management personnel transition
- Lack of detailed margin data in the summary
Key Highlights
Total revenue from operations fell to ₹9,078.10 lakhs from ₹9,861.87 lakhs YoY.
Quarter-on-quarter revenue decreased by 2.5% from ₹9,308.11 lakhs in March 2026.
Mr. Rudra Shriram appointed as Managing Director for a 5-year term effective August 15, 2026.
Outgoing CEO Mr. Akshay Dhar to focus specifically on new projects and expansion initiatives.
Subsidiary Daurala Foods & Beverages reported a net profit of ₹17.73 lakhs on revenue of ₹24.17 lakhs.
👀 What to Watch
Investors should monitor the execution of the 'new projects' mentioned as the reason for the CEO's transition, as current revenue is trending downwards. Watch for the full financial statement to assess if margins are being compressed alongside the revenue decline.
DSFCL Appoints Nitin Atroley as Independent Director for 5 Years and Alok Shriram as Chairman
DCM Shriram Fine Chemicals Limited (DSFCL) has announced key board appointments effective July 15, 2026. Mr. Nitin Atroley, a former KPMG India leader with over 30 years of experience, joins as an Independent Director for a 5-year term. Additionally, Mr. Alok Bansidhar Shriram, who has 46 years of experience and is the MD & CEO of DCM Shriram International, has been appointed as the Non-Executive Chairman for a 1-year term. These appointments are intended to strengthen the board's governance and strategic oversight capabilities.
Confidence: HIGH
What changedThe company has added a seasoned strategy professional to its board as an independent director and designated a group veteran as the new Chairman.
Why it mattersThe appointments bring significant corporate governance and strategic experience to the board, which is critical for a fine chemicals entity looking to establish its market position.
Nitin Atroley Term: 5 yearsAlok Shriram Term: 1 yearAtroley Experience: 30+ yearsShriram Experience: 46+ yearsEffective Date: July 15, 2026
📅 Short termThe announcement is procedural and unlikely to impact the stock price significantly in the immediate term.
📈 Long termThe inclusion of high-caliber professionals in governance roles is a positive structural step for long-term institutional building.
Key Highlights
Mr. Nitin Atroley appointed as Additional Director (Independent) for a 5-year term from July 15, 2026, to July 14, 2031
Mr. Alok Bansidhar Shriram appointed as Non-Executive Chairman for a 1-year term starting July 15, 2026
Mr. Atroley brings over 30 years of experience, previously serving as Chief Strategy, People and Corporate Affairs Officer at KPMG India
Mr. Shriram brings over 46 years of management experience and currently serves as MD & CEO of DCM Shriram International Limited
The board meeting concluded at 3:32 PM on July 14, 2026, following the recommendation of the Nomination and Remuneration Committee
👀 What to Watch
Investors should monitor the company's future financial filings and operational updates to see how this strengthened board leadership translates into business strategy and execution.
DSFCL Announces Maiden Dividend of ₹0.40 Per Share; Sets Record Date for July 1, 2026
DCM Shriram Fine Chemicals Limited (DSFCL) has recommended its maiden final dividend of ₹0.40 per equity share (20% of face value) for FY 2025-26. The dividend is subject to approval at the upcoming 5th Annual General Meeting (AGM) scheduled for July 14, 2026. The company has fixed July 1, 2026, as the record date for determining eligibility. Shareholders are advised to submit relevant tax documents by July 1 to ensure appropriate TDS rates are applied.
Key Highlights
Recommended a maiden final dividend of ₹0.40 per equity share of face value ₹2 (20%).
Record date for dividend eligibility and cut-off for e-voting is fixed as July 1, 2026.
The 5th Annual General Meeting is scheduled for July 14, 2026, via video conferencing.
Standard TDS of 10% applies to resident shareholders with PAN; 20% for those without valid PAN.
Remote e-voting period is set from July 9, 2026, to July 13, 2026.
👀 What to Watch
Shareholders should ensure their PAN and bank account details are updated with their Depository Participant or the Company by July 1, 2026, to avoid higher tax deduction at source.
DCM Shriram Fine Chemicals Announces ₹0.40 Dividend; Sets July 1, 2026, as Record Date
DCM Shriram Fine Chemicals Limited (DSFCL) has recommended a dividend of ₹0.40 per equity share of face value ₹2 for the financial year 2025-26. The company has fixed July 1, 2026, as the Record Date to determine shareholder eligibility for this payout. The dividend is subject to approval at the 5th Annual General Meeting (AGM) scheduled for July 14, 2026. Once approved, the payment will be processed on or before August 13, 2026.
Key Highlights
Recommended dividend of ₹0.40 per equity share (20% of face value ₹2) for FY 2025-26.
Record Date for dividend entitlement is fixed as Wednesday, July 1, 2026.
5th Annual General Meeting (AGM) to be conducted via Video Conferencing on July 14, 2026.
Share Transfer Books will remain closed from July 3, 2026, to July 14, 2026.
Dividend payment timeline is set for within 30 days of the AGM, specifically by August 13, 2026.
👀 What to Watch
Investors interested in the dividend should ensure they hold the company's shares before the ex-dividend date (typically one business day prior to the July 1 record date). Shareholders should also note the remote e-voting period from July 9 to July 13 to participate in company resolutions.
DSFCL to Hold 5th AGM on July 14, 2026; Proposes ₹0.40 Dividend per Share
DCM Shriram Fine Chemicals Limited (DSFCL) has scheduled its 5th Annual General Meeting for July 14, 2026. The Board has recommended a dividend of ₹0.40 per equity share (20% of face value ₹2) for FY 2025-26, with a record date of July 1, 2026. Key resolutions include the re-appointment of directors and an amendment to the Articles of Association to exempt the Managing Director from retirement by rotation.
Key Highlights
Proposed dividend of ₹0.40 per equity share of face value ₹2 for the financial year 2025-26.
Record date for dividend eligibility is July 1, 2026, with payment within 30 days of the AGM.
Special resolution to amend Articles of Association to allow the Managing Director to be exempt from retirement by rotation.
Approval sought for commission to Non-Executive Directors not exceeding 1% of the company's net profits.
Remote e-voting period is set from July 9, 2026, to July 13, 2026.
👀 What to Watch
Investors interested in the dividend should ensure they hold the stock before the record date of July 1, 2026. Shareholders should also review the proposed governance changes regarding director rotations and commissions.
DSFCL Recommends 20% Dividend and Approves FY26 Audited Financial Results
DCM Shriram Fine Chemicals Limited (DSFCL) has approved its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The Board has recommended a dividend of 20%, amounting to Rs. 0.40 per equity share of face value Rs. 2. The statutory auditors have issued an unmodified opinion on the financial statements, ensuring reliability in the reported figures. The company's 5th Annual General Meeting is scheduled for July 14, 2026, to seek shareholder approval for the dividend payout.
Key Highlights
Recommended a dividend of 20% (Rs. 0.40 per equity share) for the financial year 2025-26.
Approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Statutory auditors Kirtane & Pandit LLP issued an unmodified opinion on the financial results.
The 5th Annual General Meeting (AGM) is scheduled for July 14, 2026, via video conferencing.
Consolidated results include the performance of subsidiary Daurala Food & Beverages Private Limited.
👀 What to Watch
Investors should review the detailed profit and loss statements for margin trends and revenue growth. The dividend recommendation and clean audit report are positive indicators of corporate governance and cash flow.
DSFCL Recommends 20% Final Dividend of Rs. 0.40 Per Share for FY 2025-26
DCM Shriram Fine Chemicals Limited (DSFCL) has recommended a final dividend of Rs. 0.40 per equity share for the financial year ended March 31, 2026. This payout represents 20% of the face value of Rs. 2 per share. The dividend is subject to shareholder approval at the 5th Annual General Meeting (AGM) scheduled for July 14, 2026. Once approved, the payment will be disbursed to eligible shareholders within 30 days of the AGM.
Key Highlights
Recommended final dividend of 20% (Rs. 0.40 per share) for FY 2025-26
Face value of the equity shares is Rs. 2 per share
5th Annual General Meeting scheduled for July 14, 2026
Dividend to be paid within 30 days of shareholder approval at the AGM
Board approved audited standalone and consolidated financial results for the year ended March 31, 2026
👀 What to Watch
Investors seeking regular income should note the upcoming AGM on July 14, 2026, to ensure eligibility for the Rs. 0.40 per share dividend. The stock remains a watch for yield-focused portfolios following the company's audited financial performance.
DCM Shriram Fine Chemicals Reports FY26 Results; Recommends 20% Dividend
DCM Shriram Fine Chemicals Limited (DSFCL) has approved its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The Board has recommended a dividend of 20%, which translates to Rs. 0.40 per equity share with a face value of Rs. 2. The statutory auditors have provided an unmodified opinion, indicating a clean audit of the company's financial health. The company has also scheduled its 5th Annual General Meeting for July 14, 2026, to seek shareholder approval for the dividend and financial statements.
Key Highlights
Recommended a dividend of 20% (Rs. 0.40 per equity share) for the financial year 2025-26.
Audited financial results for FY26 approved with an unmodified auditor's opinion.
Consolidated results include the performance of subsidiary Daurala Food & Beverages Private Limited.
The 5th Annual General Meeting (AGM) is scheduled for July 14, 2026.
The meeting concluded with the Board's approval of both standalone and consolidated financial statements.
👀 What to Watch
Investors should monitor the detailed financial statements for revenue and profit growth trends compared to the previous year. The dividend recommendation provides a positive yield signal for long-term shareholders.
DCM Shriram Fine Chemicals Appoints Alok Bansidhar Shriram to Board Effective March 2026
DCM Shriram Fine Chemicals Limited has announced the appointment of Mr. Alok Bansidhar Shriram, effective March 03, 2026. Mr. Shriram is a seasoned professional with over 44 years of experience in senior management, currently serving as the MD and CEO of DCM Shriram International Limited. His extensive background includes leadership roles in major industry bodies like the PHD Chamber of Commerce and Industry and FICCI. This appointment is expected to bring significant strategic depth and industrial expertise to the company's leadership team.
Key Highlights
Appointment of Mr. Alok Bansidhar Shriram effective from March 03, 2026
Candidate brings over 44 years of professional experience in senior management positions
Currently serves as Managing Director & CEO of DCM Shriram International Limited
Past President of PHD Chamber of Commerce and Industry and current Executive Committee member of FICCI
Holds directorships in multiple entities including Synergy Environics and National Skill Development Corporation
👀 What to Watch
Investors should view this as a positive move for long-term governance and strategic oversight, though no immediate impact on stock performance is expected given the 2026 effective date.
DCM Shriram Fine Chemicals Appoints Alok Shriram and Sunil Mathur as Directors
DCM Shriram Fine Chemicals Limited (DSFCL) has appointed Mr. Alok Bansidhar Shriram and Mr. Sunil Behari Mathur as Additional Directors (Non-Independent, Non-Executive) effective March 03, 2026. Mr. Shriram brings over 44 years of senior management experience and currently serves as the Senior MD and CEO of DCM Shriram Industries Limited. Mr. Mathur is a former Chairman of LIC of India and the National Stock Exchange (NSE), having previously managed funds exceeding 40 billion Dollars at SUUTI. These high-profile appointments are expected to significantly strengthen the board's strategic oversight and corporate governance.
Key Highlights
Appointment of Mr. Alok Bansidhar Shriram, who has over 44 years of senior management experience, as Additional Director.
Induction of Mr. Sunil Behari Mathur, former Chairman of LIC and NSE, to the Board.
Appointments are effective from March 03, 2026, following the Board meeting held on March 02, 2026.
Mr. Mathur brings expertise from managing over 40 billion Dollars in funds as an Administrator of SUUTI.
👀 What to Watch
Investors should view these appointments as a positive development for the company's governance and strategic direction. The addition of industry veterans from the parent group and the financial sector suggests a focus on robust leadership and long-term growth.
DCM Shriram Fine Chemicals Reports Q3 FY26 Total Income of ₹97.76 Crore
DCM Shriram Fine Chemicals Limited (DSFCL) reported a consolidated total income of ₹97.76 crore for the quarter ended December 31, 2025, a marginal increase from ₹97.58 crore in the preceding quarter. For the nine-month period ended December 2025, total income stood at ₹294.49 crore, reflecting a decline from ₹319.16 crore in the corresponding period of the previous year. This marks the company's first financial disclosure following its recent listing on the BSE and NSE on February 17, 2026. The consolidated results include its subsidiary, Daurala Foods & Beverages Private Limited, which contributed ₹17 lakhs to the quarterly revenue.
Key Highlights
Consolidated total income for Q3 FY26 stood at ₹97.76 crore compared to ₹94.31 crore in Q3 FY25.
Nine-month consolidated total income decreased to ₹294.49 crore from ₹319.16 crore year-on-year.
Cost of materials consumed for the quarter was ₹54.75 crore, showing efficient cost management compared to ₹61.62 crore in Q3 FY25.
The company successfully listed its equity shares on February 17, 2026, and submitted results within the 21-day regulatory window.
Subsidiary Daurala Foods & Beverages reported a net profit of ₹12 lakhs for the quarter ended December 31, 2025.
👀 What to Watch
As this is a newly listed entity, investors should focus on the company's margin profile and revenue growth trajectory in the upcoming quarters to establish a valuation baseline. The year-to-date revenue decline suggests a need to monitor demand cycles in the fine chemicals segment.
